2010
DOI: 10.3109/13651501.2010.500737
|View full text |Cite
|
Sign up to set email alerts
|

Elevated salivary α-amylase and cortisol levels in unremitted and remitted depressed patients

Abstract: Objective. Major depressive disorder (MDD) is often associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis via chronic stress. Psychosocial stress-induced activation of salivary α-amylase (sAA) represents sympathoadrenal medullary system (SAM) activity, and sAA has become an emerging biomarker for sympathetic nervous system activity. In contrast to salivary cortisol, sAA has been less extensively studied in depressed patients. The present study sought to address this problem by measurin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
23
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(26 citation statements)
references
References 30 publications
3
23
0
Order By: Relevance
“…Previous research in non-pregnant participants has reported significant associations between depressive symptoms and increased sAA concentrations (Ishitobi et al, 2010;Tanaka et al, 2012;Veen et al, 2013), however such associations appear to be stronger in unremitted (Ishitobi et al, 2010) and female patients (Tanaka et al, 2012). Further, sAA levels have been related to antidepressant use; there is evidence to suggest that those patients using tri-cyclic antidepressant medication have higher sAA levels than those who use selective serotonin re-uptake inhibitors (Veen et al, 2013).…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…Previous research in non-pregnant participants has reported significant associations between depressive symptoms and increased sAA concentrations (Ishitobi et al, 2010;Tanaka et al, 2012;Veen et al, 2013), however such associations appear to be stronger in unremitted (Ishitobi et al, 2010) and female patients (Tanaka et al, 2012). Further, sAA levels have been related to antidepressant use; there is evidence to suggest that those patients using tri-cyclic antidepressant medication have higher sAA levels than those who use selective serotonin re-uptake inhibitors (Veen et al, 2013).…”
Section: Discussionmentioning
confidence: 91%
“…Increased sAA in response to acute stress has also been associated with the expected increase in circulating noradrenaline (Rohleder et al, 2004;Thoma et al, 2012). Further, sAA levels have also been reported to be inflated in people with depression (Ishitobi et al, 2010;Tanaka et al, 2012;Veen et al, 2013).…”
Section: Introductionmentioning
confidence: 96%
“…Nonetheless, systematic clinical data on sAA levels in MDD according to STAI profile are limited to a single study in 71 depressed patients where sAA levels were significantly increased in unremitted patients with MDD compared to both healthy controls and remitted patients with MDD. Still, STAI scores (State or Trait) were not associated with sAA level although STAI measurements in unremitted patients with MDD were significantly increased compared with healthy controls and remitted patients (3). Thus anxiety levels in MDD might not be associated with sAA or salivary cortisol levels.…”
Section: Introductionmentioning
confidence: 84%
“…There is, however, considerable inconsistency in the results attributing sAA elevation to illness stage, severity, specific dimensions of depression and measures of distress (3,4). The elevated sAA activity was associated with depression severity and specific psychopathological dimensions of MDD with anxiety being attributed to distress.…”
Section: Introductionmentioning
confidence: 99%
“…For this reason, the measurement of sAA activity was used in the study, to investigate the psychobiology of stress, suggesting the existence of a correlation with various acute and chronic stress-connected diseases. [2][3][4] According to the recent literature, subjects afflicted with chronic pain, among which temporomandibular disorders (TMD), suffer from a dysregulation of the descending systems of pain modulation (and the periaqueductal gray plays a key role) and of the hypothalamic-pituitary-adrenal axis (HPA) that can be evaluated through the study of the plasmatic cortisol. [5][6][7] Plasmatic cortisol levels are correlated with the salivary cortisol and sAA levels.…”
mentioning
confidence: 99%